Spire Health has launched a research study on COPD exacerbations using continuous respiratory sensors to assess adherence and identify digital biomarkers preceding exacerbations.
Spire Health, a US-based continuous respiration sensing and high-adherence ambulatory monitoring healthcare company, is poised to revolutionise the wearable tech space for use in clinical s
Journey Medical has claimed FDA approval for its Emrosi therapy for rosacea, which it thinks could become a "standard of care" drug for the common skin disorder.
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.